References
- Anal AK, Stevens WF, Remunan-Lopez C. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int J Pharm 2006; 312: 166–173
- Ankerst J. Combination inhalers containing inhaled corticosteroids and long-acting beta(2)-agonists: Improved clinical efficacy and dosing options in patients with asthma. J Asthma 2005; 42: 715–724
- Black SD, Mould DR. Amino acid scale: Hydrophobicity of physiological L-alpha amino acids. Anal Biochem 1991; 193: 72–82
- Blanco MD, Sastre RL, Teijon C, Olmo R, Teijon JM. Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Int J Pharm 2006; 326: 139–147
- Bosquillon C, Lombry C, Preat V, Vanbever R. Comparison of particle sizing techniques in the case of inhalation dry powders. J Pharm Sci 2001a; 90: 2032–2041
- Bosquillon C, Lombry C, Preat V, Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Contr Rel 2001b; 70: 329–339
- Bosquillon C, Prat W, Vanbever R. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Contr Rel 2004; 96: 233–244
- Bosquillon C, Rouxhet PG, Ahimou F, Simon D, Culot C, Preat V, et al. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J Contr Rel 2004; 99: 357–367
- Cilurzo F, Selmin F, Minghetti P, Rimoldi I, Damartin F, Montanari L. Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam. Eur J Pharm Sci 2005; 24: 355–361
- De Villiers MM. Paper flow and compressibility. Theory and practice of contemporary pharmaceuticals, TK Ghosh, BR Jasti. CRC Press, Boca Raton 2005; 298–299
- Dyer MJ, Halpin DMG, Stein K. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: A systematic review. BMC Fam Pract 2006; 7: 34
- Learoyd TP, Seville PC. Respirable powders. 2007, Worldwide Patent, 31.05.2007
- Learoyd TP, Burrows JL, French E, Seville PC. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm 2008a; 68: 224–234
- Learoyd TP, Burrows JL, French E, Seville PC. Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. Powder Tech 2008b; 187: 231–238
- Li HY, Birchall J. Chitosan-modified dry powder formulations for pulmonary gene delivery. Pharm Res 2006; 23: 941–950
- Li HY, Seville PC, Williamson IJ, Birchall JC. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J Gene Med 2005; 7: 343–353
- Lotvall J. The long and short of beta(2)-agonists. Pulmon Pharmacol Therapeut 2002; 15: 497–501
- Moffat AC, Osselton DM, Widdop B, Laurent GY. Clarke's analysis of drugs and poisons. Pharmaceutical Press, London 2004
- Reid ML, Brown MB, Moss GP, Jones SA. An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes. J Pharm Pharmacol 2008; 60: 1139–1147
- Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate—poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006; 27: 4239–4249
- Seville PC, Learoyd TP, Li HY, Williamson IJ, Birchall JC. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Tech 2007; 178: 40–50
- Seville PC, Li HY, Learoyd TP. Spray-dried powders for pulmonary drug delivery. Crit Rev Ther Drug Carrier Syst 2007; 24: 307–360
- Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The development of a modified dissolution method suitable for investigating powder mixtures. Drug Dev Ind Pharm 2002; 28: 1147–1153
- Siepmann J, Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139–157
- Stempel DA, Stoloff SW, Rosenzweig JRC, Stanford RH, Ryskina KL, Legorreta AP. Adherence to asthma controller medication regimens. Respir Med 2005; 99: 1263–1267
- Taki M, Zeng XM, Oliver M, Marriott C, Martin GP. A comparison of the in-vitro deposition profiles of drugs from a combination dry powder inhaler (DIPI) using the Next Generation Impactor (NGI). J Pharm Pharmacol 2006; 58: A65
- Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res 2008; 25: 999–1022